Impact of Untreated Psychosis Duration on Short-Term Outcomes in Initial Episodes of Schizophrenia - Report - MDSpire

Impact of Untreated Psychosis Duration on Short-Term Outcomes in Initial Episodes of Schizophrenia

  • By

  • Dinghui Wang

  • Kaiguo Zhang

  • Zhi Xun Zhang

  • Qingqing Zhang

  • Min Liu

  • Yanhong Huang

  • Zhenqiang Xu

  • April 29, 2026

  • 0 min

Share

Clinical Report: Impact of Untreated Psychosis Duration on Short-Term Outcomes

Overview

This study investigates the impact of duration of untreated psychosis (DUP) on symptom improvement in first-episode schizophrenia patients. Results indicate that shorter DUP is associated with significantly greater symptom improvement, particularly in patients with higher baseline symptom severity.

Background

Schizophrenia is a chronic and severe mental disorder that significantly impacts global health and disability. The duration of untreated psychosis (DUP) is a critical factor influencing treatment outcomes, with evidence suggesting that shorter DUP correlates with better symptomatic and functional recovery. Understanding the implications of DUP is essential for improving early intervention strategies and patient prognosis.

Data Highlights

DUP CategoryMean BPRS Improvement (Points)95% CI
Short (≤26 weeks)11.505.92 to 17.08
Long (>26 weeks)3.57-0.91 to 7.05

Key Findings

  • Patients with short DUP showed greater BPRS improvement than those with long DUP (mean difference 11.50 points).
  • Long DUP was associated with less symptom improvement in the adjusted Bayesian model (posterior median β = -3.93).
  • Higher baseline BPRS scores correlated with greater symptom improvement (posterior median β = 0.66).
  • The adverse effects of long DUP were more pronounced in patients with higher baseline symptom severity (interaction P = 0.014).
  • Shorter DUP serves as a clinically useful prognostic indicator for first-episode schizophrenia outcomes.

Clinical Implications

Clinicians should prioritize early detection and intervention in first-episode schizophrenia to minimize DUP. The findings underscore the importance of timely treatment initiation, particularly for patients presenting with higher symptom severity, to enhance recovery outcomes.

Conclusion

Shorter duration of untreated psychosis is linked to improved symptom outcomes in first-episode schizophrenia patients. These results highlight the necessity for early intervention strategies to optimize patient care.

References

  1. BMC Psychiatry, 2025 -- Effectiveness of implementing family involvement on patient outcomes in individuals with psychotic disorders
  2. Drugs - Real World Outcomes, 2016 -- Long-Term Continuation of Antipsychotic Therapy in Older Adults with Dementia
  3. BMC Psychiatry, 2025 -- Longitudinal Analysis of Recovery Domains in Patients with Schizophrenia Spectrum Disorders
  4. Psychosocial Management of First-Episode Psychosis and Schizophrenia: Synopsis of the US Department of Veterans Affairs and US Department of Defense Clinical Practice Guidelines
  5. Molecular Psychiatry, 2025 -- Rate and predictors of remission and recovery in first-episode psychosis
  6. BMC Psychiatry (Springer) — A definitive randomised controlled trial of a group mindfulness-based psychological therapy for people with psychosis: the MIND-P study
  7. Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis
  8. The impact of Duration of Untreated Psychosis on functioning and quality of life over one year of Coordinated Specialty Care
  9. Psychosocial Management of First-Episode Psychosis and Schizophrenia: Synopsis of the US Department of Veterans Affairs and US Department of Defense Clinical Practice Guidelines
  10. Rate and predictors of remission and recovery in first-episode psychosis: A 12-year follow-up of randomized-controlled trial on early intervention | Molecular Psychiatry
  11. https://www.qualityhealth.org/bree/wp-content/uploads/sites/8/2025/04/Evidence-Table-Word-Doc-FEP.pdf
  12. Impact of duration of untreated psychosis on early clinical outcomes in drug-naïve schizophrenia: A 12-week follow-up study - PubMed

Original Source(s)

Impact of Untreated Psychosis Duration on Short-Term Outcomes in Initial Episodes of Schizophrenia

  • by Dinghui Wang, Kaiguo Zhang, Zhi Xun Zhang, Qingqing Zhang, Min Liu, Yanhong Huang, Zhenqiang Xu

  • April 29, 2026

Related Content

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

A rare case of isovaleric acidemia and schizophrenia: a case report